Home › Funds › B. Metzler seel. Sohn & Co. AG › ABBV

B. Metzler seel. Sohn & Co. AG position in ABBV

ABBVIE INC · Health Care

B. Metzler seel. Sohn & Co. AG reported holding 853,280 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$223.2M, representing 1.94% of its reported portfolio and ranking #11 among its reported holdings. B. Metzler seel. Sohn & Co. AG has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)853.28K sh
Reported value held$223.21M
Portfolio Weight1.94%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How B. Metzler seel. Sohn & Co. AG's ABBV position evolved

B. Metzler seel. Sohn & Co. AG first disclosed a stake in ABBV in Q3 2023 at 353,882 shares (US$52.7M). The position peaked in Q3 2026 at 853,280 shares, worth US$223.2M. Across 13 filings, B. Metzler seel. Sohn & Co. AG increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 853,280 shares valued at US$223.2M — a reduction of -14,341 shares quarter over quarter.. Notable position changes include a 67% increase in Q4 2025 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 353.88K $52.75M New
Q4 2023 382.46K $59.27M Add
Q1 2024 456.71K $83.17M Add
Q2 2024 490.62K $84.15M Add
Q3 2024 452.81K $89.42M Reduce
Q4 2024 435.53K $77.29M Reduce
Q1 2025 484.80K $101.57M Add
Q2 2025 470.72K $87.37M Reduce
Q3 2025 498.62K $115.45M Add
Q4 2025 833.68K $190.66M Add
Q1 2026 950.38K $206.70M Add
Q2 2026 867.62K $218.33M Reduce
Q3 2026 853.28K $223.21M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has B. Metzler seel. Sohn & Co. AG held ABBV?

B. Metzler seel. Sohn & Co. AG has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is B. Metzler seel. Sohn & Co. AG's current position in ABBV?

As of Q3 2026, B. Metzler seel. Sohn & Co. AG holds 853.28K shares of ABBV (ABBVIE INC), valued at $223.21M, representing 1.94% of its reported portfolio and ranking #11.

Has B. Metzler seel. Sohn & Co. AG been buying or selling ABBV?

In the latest 13F filing (Q3 2026), B. Metzler seel. Sohn & Co. AG reduced its position in ABBV. The position peaked in Q3 2026 at 853.28K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.